T1	Participants 35 59	autism spectrum disorder
T2	Participants 74 149	Research Units on Pediatric Psychopharmacology (RUPP) Autism Network trials
T3	Participants 460 569	Study 1 included 52 subjects assigned to placebo and 49 subjects to risperidone under double-blind conditions
#1	AnnotatorNotes T3	2 groups in study one
T4	Participants 571 690	Study 2 included 49 subjects assigned to risperidone only and 75 subjects assigned to risperidone plus parent training.
#2	AnnotatorNotes T4	two groups in study 2
